Manoj Samant

441 total citations
22 papers, 351 citations indexed

About

Manoj Samant is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, Manoj Samant has authored 22 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Reproductive Medicine. Recurrent topics in Manoj Samant's work include Chemical Synthesis and Analysis (6 papers), Hypothalamic control of reproductive hormones (4 papers) and Estrogen and related hormone effects (3 papers). Manoj Samant is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Hypothalamic control of reproductive hormones (4 papers) and Estrogen and related hormone effects (3 papers). Manoj Samant collaborates with scholars based in United States, Spain and Italy. Manoj Samant's co-authors include Jean Rivier, Glenn Croston, Catherine Rivier, Darshan Ranganathan, Lawrence J. D’Souza, Isabella L. Karle, Krystyna Tatarkiewicz, John F. Paolini, David G. Parkes and Christy R. Grace and has published in prestigious journals such as Journal of the American Chemical Society, Circulation and Blood.

In The Last Decade

Manoj Samant

22 papers receiving 345 citations

Peers

Manoj Samant
Alexandra Hicks United States
Hina Khan United States
Zhe Guan China
Yuji Saita Japan
Argyris Dritselis United States
Roland Blanqué Belgium
Hideo Yoshizaki Japan
Magdalena Birker Switzerland
Jesús Solera Spain
S Caltabiano United States
Alexandra Hicks United States
Manoj Samant
Citations per year, relative to Manoj Samant Manoj Samant (= 1×) peers Alexandra Hicks

Countries citing papers authored by Manoj Samant

Since Specialization
Citations

This map shows the geographic impact of Manoj Samant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manoj Samant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manoj Samant more than expected).

Fields of papers citing papers by Manoj Samant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manoj Samant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manoj Samant. The network helps show where Manoj Samant may publish in the future.

Co-authorship network of co-authors of Manoj Samant

This figure shows the co-authorship network connecting the top 25 collaborators of Manoj Samant. A scholar is included among the top collaborators of Manoj Samant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manoj Samant. Manoj Samant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Besse, B., Alexander Drilon, BC Cho, et al.. (2024). 1256MO Phase I/II ARROS-1 study of zidesamtinib (NVL-520) in ROS1 fusion-positive solid tumours. Annals of Oncology. 35. S804–S805. 6 indexed citations
2.
Samant, Manoj, John A. Ziemniak, & John F. Paolini. (2023). First-in-Human Phase 1 Randomized Trial with the Anti-CD40 Monoclonal Antibody KPL-404: Safety, Tolerability, Receptor Occupancy, and Suppression of T-Cell–Dependent Antibody Response. Journal of Pharmacology and Experimental Therapeutics. 387(3). 306–314. 5 indexed citations
3.
Yap, Timothy A., Andrés Cervantes, Gerald S. Falchook, et al.. (2023). Abstract CT109: First-in-class first-in-human phase 1 trial and translational study of the mono(ADP-ribose) polymerase-7 (PARP7) inhibitor RBN-2397 in patients with selected advanced solid tumors. Cancer Research. 83(8_Supplement). CT109–CT109. 1 indexed citations
4.
Cid, María C., Sebastian Unizony, Daniël Blockmans, et al.. (2022). Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Annals of the Rheumatic Diseases. 81(5). 653–661. 82 indexed citations
5.
Imazio, Massimo, Allan L. Klein, Antonio Abbate, et al.. (2022). Abstract 11653: Prolonged Rilonacept Treatment in Rhapsody Long-Term Extension Provided Persistent Reduction of Pericarditis Recurrence Risk. Circulation. 146(Suppl_1). 5 indexed citations
6.
7.
Shustov, Andrei R., Amitkumar Mehta, Lubomir Sokol, et al.. (2018). Pseudoprogression (PsP) in Patients with Peripheral T-Cell Lymphoma (PTCL) Treated with the Novel Stapled Peptide ALRN-6924, a Dual Inhibitor of MDMX and MDM2. Blood. 132(Supplement 1). 5348–5348. 4 indexed citations
8.
Levy, Odile E., Carolyn M. Jodka, Manoj Samant, et al.. (2014). Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action. PLoS ONE. 9(2). e87704–e87704. 42 indexed citations
9.
Trevaskis, James L., Changqi Sun, Jennifer Athanacio, et al.. (2014). Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet‐induced obese and leptin‐deficient rodents. Diabetes Obesity and Metabolism. 17(1). 61–73. 50 indexed citations
10.
Érchegyi, Judit, Christy R. Grace, Manoj Samant, et al.. (2008). Ring Size of Somatostatin Analogues (ODT-8) Modulates Receptor Selectivity and Binding Affinity. Journal of Medicinal Chemistry. 51(9). 2668–2675. 25 indexed citations
11.
Grace, Christy R., Judit Érchegyi, Manoj Samant, et al.. (2008). Ring Size in Octreotide Amide Modulates Differently Agonist versus Antagonist Binding Affinity and Selectivity. Journal of Medicinal Chemistry. 51(9). 2676–2681. 22 indexed citations
12.
Samant, Manoj & Jean Rivier. (2007). Synthesis of protected norcysteines for SPPS compatible with Fmoc strategy. Tetrahedron Letters. 48(29). 5107–5110. 2 indexed citations
13.
Samant, Manoj, Richard White, Glenn Croston, et al.. (2007). Structure−Activity Relationship Studies of Gonadotropin-Releasing Hormone Antagonists ContainingS-Aryl/Alkyl Norcysteines and Their Oxidized Derivatives. Journal of Medicinal Chemistry. 50(9). 2067–2077. 12 indexed citations
14.
Samant, Manoj & Jean Rivier. (2006). Norcystine, a New Tool for the Study of the Structure−Activity Relationship of Peptides. Organic Letters. 8(11). 2361–2364. 13 indexed citations
15.
Samant, Manoj, et al.. (2006). Novel Analogues of Degarelix Incorporating Hydroxy-, Methoxy-, and Pegylated-Urea Moieties at Positions 3, 5, 6 and the N-Terminus. Part III. Journal of Medicinal Chemistry. 49(12). 3536–3543. 13 indexed citations
16.
Samant, Manoj, et al.. (2005). Synthesis, in vivo and in vitro biological activity of novel azaline B analogs. Bioorganic & Medicinal Chemistry Letters. 15(11). 2894–2897. 8 indexed citations
17.
Samant, Manoj, Charleen Miller, S. C. Koerber, et al.. (2005). Synthesis and biological activity of GnRH antagonists modified at position 3 with 3‐(2‐methoxy‐5‐pyridyl)‐alanine*. Journal of Peptide Research. 65(2). 284–291. 5 indexed citations
18.
Samant, Manoj, et al.. (2005). Iterative Approach to the Discovery of Novel Degarelix Analogues:  Substitutions at Positions 3, 7, and 8. Part II. Journal of Medicinal Chemistry. 48(15). 4851–4860. 13 indexed citations
19.
Samant, Manoj, et al.. (2004). Novel gonadotropin‐releasing hormone antagonists with substitutions at position 5. Biopolymers. 80(2-3). 386–391. 13 indexed citations
20.
Ranganathan, Darshan, et al.. (2002). Design, synthesis and membrane ion transport properties of cystine- and serine-based cyclo -4-oxa-heptane-1,7-bisamides. Tetrahedron Letters. 43(29). 5145–5147. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandra Hicks Breakdown of academic impact, for papers by Hina Khan Breakdown of academic impact, for papers by Zhe Guan Breakdown of academic impact, for papers by Yuji Saita Breakdown of academic impact, for papers by Argyris Dritselis Breakdown of academic impact, for papers by Roland Blanqué Breakdown of academic impact, for papers by Hideo Yoshizaki Breakdown of academic impact, for papers by Magdalena Birker Breakdown of academic impact, for papers by Jesús Solera Breakdown of academic impact, for papers by S Caltabiano
Rankless by CCL
2026